Cognition Therapeutics, Inc. · NASDAQ:CGTX
AARON G.L. FLETCHER reported a 6.90% stake in Cognition Therapeutics, Inc. (Schedule 13D/A)
Event Sep 19, 2025 · Filed Sep 23, 2025
AARON G.L. FLETCHER reported a 6.90% stake in Cognition Therapeutics, Inc., 6,059,555 shares, with active intent on Sep 19, 2025. Filed Sep 23, 2025 (Schedule 13D/A).
- Stake
- 6.90%
- Shares
- 6,059,555
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 22 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOS MEMORY SPV I, LP | 1.60% | 1,424,014 |
| BIOS MEMORY SPV II, LP | 0.40% | 385,248 |
| BIOS FUND I, LP | 0.50% | 418,926 |
| BIOS FUND I QP, LP | 0.30% | 245,029 |
| BP DIRECTORS, LP | 0.04% | 32,328 |
| BIOS FUND II, LP | 0.10% | 78,298 |
| BIOS FUND II QP, LP | 0.30% | 255,765 |
| BIOS FUND II NT, LP | 0.04% | 34,238 |
| BIOS FUND III, LP | 0.40% | 309,748 |
| BIOS FUND III QP, LP | 2.30% | 2,021,906 |
| BIOS FUND III NT, LP | 0.40% | 326,733 |
| BIOS CLINICAL OPPORTUNITY FUND, LP | 0.60% | 500,095 |
| BIOS EQUITY PARTNERS, LP | 1.20% | 1,081,531 |
| BIOS EQUITY PARTNERS II, LP | 0.40% | 368,301 |
| BIOS EQUITY PARTNERS III, LP | 3.00% | 2,658,387 |
| BIOS EQUITY COF, LP | 0.60% | 500,095 |
| CAVU MANAGEMENT, LP | 6.30% | 5,532,233 |
| BIOS CAPITAL MANAGEMENT, LP | 6.80% | 6,032,328 |
| CAVU ADVISORS, LLC | 6.30% | 5,532,233 |
| BIOS ADVISORS GP, LLC | 6.80% | 6,032,328 |
| LESLIE W. KREIS | 6.30% | 5,532,233 |
| AARON G.L. FLETCHER | 6.90% | 6,059,555 |